ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $22,615,401 | -3.2% | 2,960,131 | -9.7% | 0.30% | -10.4% |
Q3 2022 | $23,351,000 | -18.4% | 3,279,620 | -7.3% | 0.34% | -17.3% |
Q2 2022 | $28,631,000 | -34.4% | 3,539,055 | +12.5% | 0.40% | -20.1% |
Q1 2022 | $43,657,000 | -21.0% | 3,145,293 | +59.8% | 0.51% | -10.9% |
Q4 2021 | $55,234,000 | +21.6% | 1,968,431 | +47.3% | 0.57% | +23.4% |
Q3 2021 | $45,411,000 | +15.5% | 1,336,023 | +38.8% | 0.46% | +20.1% |
Q2 2021 | $39,322,000 | – | 962,352 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |